| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 150/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
|
Name
|
Methylglucamine Meglumine |
|
EINECS No
|
6284-40-8
|
|
Appearance
|
White Powder
|
|
Purity
|
98%
|
|
Package
|
Bag/drum/OEM
|
Clinical treatment: 1. Heart failure: It has good effect on heart failure caused by various reasons, such as hypertensive heart disease, coronary atherosclerotic heart disease (coronary heart disease) and cardiomyopathy. 2. Coronary atherosclerotic heart disease (coronary heart disease): This product can reduce myocardial oxygen consumption, improve myocardial cell metabolism, and protect ischemic and hypoxic myocardium; At the same time, it can expand coronary artery, improve coronary circulation, and increase myocardial oxygen supply, so it is suitable for the treatment of acute myocardial infarction, and has a definite effect on stable exertional angina pectoris. 3. Acute myocarditis: There is varying degrees of improvement or recovery in heart failure, ventricular tachycardia, and atrioventricular block caused by myocarditis, and an enlarged heart can shrink. 4. Dilated cardiomyopathy: After medication, cardiac function and electrocardiogram have improved, and some patients' enlarged hearts have significantly shrunk or returned to normal. 5. Sick sinoatrial node syndrome: applicable to early or evolving patients. It can recover sinus quiescence, sinus block, slow fast syndrome to varying degrees. 6. Ventricular premature beats: It has certain therapeutic effects on ventricular premature beats and other arrhythmias caused by various reasons, and can be used as an auxiliary drug for treating arrhythmias.
){kind=link}